Efficacy and safety of erenumab in women with a history of menstrual migraine
We performed a post hoc, subgroup analysis of a phase 3, randomized, double-blind, placebo-controlled study of erenumab for prevention of episodic migraine (STRIVE) to determine the efficacy and safety of eren...
21:95
The Journal of Headache and Pain 2020
No hay comentarios:
Publicar un comentario